DON'T MISS THESE UPDATES FOR THIS INICET May! 💥 #aiims #inicet #neet #neetpg #doctor

本站添加: 2026-05-15

[00:00:06]Hello everyone, welcome back to my channel. Myself Dr. Akash and today I'm going to discuss about recent updates which are important for upcoming INIC exam. First in PSM uh first update is Jani portal. It has been launched in 7th May 2026. It is the journey of antiatal, natal and postnatal care. It is a serviceoriented digital platform designed comprehensively to monitor and maintain digital health records of women during their reproductive age. It has been developed as an upgraded version of existing RCH portal and this platform creates a longitudinal health record by capturing key service delivery events across continum of care. It aims seamless tracking of maternal and child health services. Next is census 2007 mascot Vikash and Pragati. Because is the male enumerator and progati is the female enumerator. It represent gender equality. It promotes people's participation.

[00:01:20]Next is CMMS portal that is census management and monitoring system. Next is mana framework for AI. You can uh see the expansion of the acronym. The next is Sahi strategy for artificial intelligence in healthcare for India.

[00:01:39]Both it is the benchmark opening data platform for health AI. Next is eat right movement by government of India.

[00:01:49]It has three pillars safety healthy and sustainable. Next is world health day 2026 theme together for health stand with science.

[00:02:00]Next is indigenous vaccine for malaria that is adalivax and new vaccine for deno has been approved recently that is qenga.

[00:02:12]Next is who TV regimen for drug sensitive TV. It is a 4 month regimen that is 2 hmppz and 2 hpm. H for isia, P for refendent, M for moxyloxxin and Z for pyroenomitein.

[00:02:31]It is still not adopted in India. You can see the eligibility criteria that is weight should be more than 40 kg and age should be more than equal to 12 years.

[00:02:42]Next is mission age Suraka. Now it is 95 95 99 approach. Previously it was 95 95 95. Next is dam. It is the malaria control program in tribal areas and hati that is malaria elimination initiative.

[00:03:03]So PSM is complete now. Next is pharmacology. All the drugs which has been recently approved I have tried to compile. Let's start. First is be strand. It is the new drug approved for year positive heart to negative breast cancer. Next is trardipetan. It is an NK1 inhibitor. It has been approved for prevention of motion sickness. Next is bremonine tartarate and carbakol opthalmic solution. It has been approved for presopia in adults. Next is sueten that is a sodium channel blocker has been approved for acute pain.

[00:03:45]Next is fitoeran that is an anti-throbin directed sRNA for profile axis in hemophilia A or B. Next is neocalimab that is a neonatal FC receptor blocker and it has been approved for generalized myastinia gravis.

[00:04:04]Next is lenapafir that is HIV1 capsit protein inhibitor. It has been approved for preexposure profile access in HIV1.

[00:04:16]Next is brain society that is diiptidile peptide one inhibitor and it has been approved for bronchasis that is non-cystic fibrosis bronchetis. Next is metavipad that is pyroatekinus inhibitor. It has been approved in adults with alpha or betthalmia.

[00:04:39]Next is nandom milast that is PDE4 inhibitor and it has been approved in idiopathic pulmonary fibrosis.

[00:04:49]Next is copper histinate.

[00:04:52]It is a copper replacement therapy and it has been approved for menage disease.

[00:04:58]Next is resetum. It is a thyroid receptor beta antagonist and it has been approved for mash that is metabolic dysfunction associated stato hepatitis and it was formerly known as nash. Next is barricetinip that is jack inhibitor and it has been approved for alopeesia ariata.

[00:05:22]Next is TJetite that is dual GLP-1 and GIB receptor agonist which has been approved for obstructive sleep apnea.

[00:05:32]Next is a newer antibiotic nafitroycin.

[00:05:35]It is a fourth generation macrolyte and it has been approved for hospitalacquired pneumonia for various organisms. Next is bonobrazen that is novel potassium competitive acid blocker and it has been approved for GRD HP infection. Next is sephim in metadobactum combination that has been approved for complicated UT. Next is insulin ic. It is a once weekly vessel insulin analog. Next is orphog lipron that is oral GLP1 agonist approved for obesity recently. Next is Navitide and Boseritide that is C type nateritic peptide inhibitor of FGF23 and it has been approved for aondroplasia.

[00:06:25]Next is palusotin that is oral somatin receptor type 2 agonist and it has been approved for acromegali. Next is atrium nazal spray.

[00:06:38]It is a calcium channel blocker and it has been approved for PSVT that is paroxismal supra ventricular tracheic cardium. Next is aampton and mavacon that is meosin inhibitor and it is also a calcium sensitizer and it has been approved for hypertrophic obstructive cardiammyopathy as a second line drug. Next is leeroce that is a PCSK9 inhibitor and it has been approved for hyper cholesterolmia.

[00:07:12]Next is depoab that is IL5 inhibitor and it has been approved for severe eosinophilic asthma and it has it is the longest acting monocular antibbody for asthma.

[00:07:26]Next is defamast that is PDE4 inhibitor and it has been approved for attopic dermatitis. Next is linery bat that is ideal bileacy transporter inhibitor and it has been approved for cholestatic puritis associated with primary bilary colangitis.

[00:07:47]Next is jolly and jotidacin. Jollifin is toquisome 2 inhibitor and jeepotidasin is to topoisome 4 and DNA gyus inhibitor and both has been approved for gonoria. Next is vimkininoa vaccine that is approved for chicken.

[00:08:10]Next cromab it has been approved for profile access for RSV virus. Next is elenetant and phasolinant. Elenotant is NK1 and3 receptor inhibitor and fasolinitant is NK3 receptor inhibitor.

[00:08:29]Both has been approved for post-menopausal hot flashes. Next is asylin. It is a cholineic analog and it has been approved for prebiopia.

[00:08:41]Next is imlun strand that is selective estrogen receptor down regulator and it has been approved for breast cancer with ESR1 mutation. Next is a procetent that is endotheline receptor antagonist like bossent ambresent and it has been approved for systemic hypertension. Next is subpidonium that is anticolinergic analog and it has been approved for axillary hyperhydrosis as a topical application. Next is zenomelain that is M1 M4 agonist. It [clears throat] has been approved for psychosis recently. Next is landol that is shortest acting beta blocker and it has been approved for acute rate control for atrial fibrillation. Next is leanob that is humanized IGG1 monoconal antibbody that binds to a beta soluble proto fibbrals and it has been approved for early onset Alzheimer disease. Next is paloptocogen roxa.

[00:09:55]It is adenoirus associated vector based gene therapy and it has been approved for severe hemophilia A.

[00:10:04]So pharmacology is complete. Now OBG in OBG first is PCO is now known as POS that is polyendocrine metabolic ovarian syndrome and second torch infection is now known as scorch that is cphilis CMV others reubella chickenpox and HSP there are so many updates right now but I feel these are the most important things you need to know or you may need to know for INIC. Tomorrow is the exam. So don't go for details of these updates. Just go through it once so that so that the names can strike in your mind during the exam. So best wishes for you guys and thank you.